Entrada Therapeutics, Inc. – Trademark Portfolio
Entity Type: 03
Entrada Therapeutics, Inc. holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 8 trademarks are registered and 3 are pending. Notable registered marks include ENTRADA, ENTRADA DREAMS, and ENTRADA THERAPEUTICS. The owner is based in Boston, MA.
One Design Center Pl, Suite 17-500
Boston, MA 02210
Showing of trademarks Trademarks
Trademark Classifications
Entrada Therapeutics, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Entrada Therapeutics, Inc. have?
Entrada Therapeutics, Inc. has 13 U.S. trademarks filed with the USPTO. Of these, 8 registered, 3 pending, 2 abandoned.
What trademark classes does Entrada Therapeutics, Inc. file in?
Entrada Therapeutics, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Entrada Therapeutics, Inc.'s most well-known trademarks?
Entrada Therapeutics, Inc.'s registered trademark portfolio includes well-known marks such as ENTRADA, ENTRADA DREAMS, and ENTRADA THERAPEUTICS. These are among 8 currently registered trademarks in the portfolio.
What is Entrada Therapeutics, Inc.'s trademark registration success rate?
Entrada Therapeutics, Inc. has a 80% trademark registration rate, with 8 out of 10 resolved applications resulting in successful registration. Currently, 3 applications are pending review.